Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management - Archive ouverte HAL Access content directly
Journal Articles Brain Sciences Year : 2021

Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management

Abstract

Patients with Parkinson disease (PD) experience a range of non-motor symptoms, including gastrointestinal symptoms. These symptoms can be present in the prodromal phase of the disease. Recent advances in pathophysiology reveal that α-synuclein aggregates that form Lewy bodies and neurites, the hallmark of PD, are present in the enteric nervous system and may precede motor symptoms. Gastroparesis is one of the gastrointestinal involvements of PD and is characterized by delayed gastric emptying of solid food in the absence of mechanical obstruction. Gastroparesis has been reported in nearly 45% of PD. The cardinal symptoms include early satiety, postprandial fullness, nausea, and vomiting. The diagnosis requires an appropriate test to confirm delayed gastric emptying, such as gastric scintigraphy, or breath test. Gastroparesis can lead to malnutrition and impairment of quality of life. Moreover, it might interfere with the absorption of antiparkinsonian drugs. The treatment includes dietary modifications, and pharmacologic agents both to accelerate gastric emptying and relieve symptoms. Alternative treatments have been recently developed in the management of gastroparesis, and their use in patients with PD will be reported in this review.

Dates and versions

hal-03304658 , version 1 (28-07-2021)

Identifiers

Cite

Heithem Soliman, Benoit Coffin, Guillaume Gourcerol. Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management. Brain Sciences, 2021, 11 (7), pp.831. ⟨10.3390/brainsci11070831⟩. ⟨hal-03304658⟩
18 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More